BAKTERIENTHERAPIE FÜR CLOSTRIDIUM-DIFFICILE-COLITIS
European patent · EP3564357 · In force
Register entry
- Publication number
- EP3564357
- Application number
- EP19176151
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 1, 2011
- Published
- Nov 6, 2019
- Granted
- Apr 6, 2022
- Protection ends at the latest
- Jan 31, 2031
- Next annual fee due
- Feb 28, 2027
- IPC classes
- C12N 1/04 (2006.01)A61K 35/741 (2015.01)A61K 35/74 (2015.01)A61K 9/20 (2006.01)G01N 33/569 (2006.01)C12N 1/20 (2006.01)A61P 1/00 (2006.01)A61P 1/12 (2006.01)A61P 31/04 (2006.01)
- Priority
- US 33728310 P 01.02.2010US 35118410 P 03.06.2010
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 1, 2026
Change
Published in Swissreg on 01.03.2026
- Mar 21, 2025
Holder’s address changed
- Owner
- Rebiotix, Inc., 2660 Patton Road, Roseville, Minnesota 55113, USA → Ferring Microbiome Inc., 2660 Patton Road, Roseville, Minnesota 55113, USA
Published in Swissreg on 21.03.2025
- Mar 1, 2025
Change
Published in Swissreg on 01.03.2025
- Mar 1, 2024
Change
Published in Swissreg on 01.03.2024
- Mar 7, 2023
Change
Published in Swissreg on 07.03.2023
- Mar 6, 2023
Change
Published in Swissreg on 06.03.2023
- Jan 9, 2023
Address changed
- Representative
- ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich → Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg
Published in Swissreg on 09.01.2023
- May 18, 2022
Agent entered
- Representative
- ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich
Published in Swissreg on 18.05.2022
1 earlier entry
- Apr 6, 2022
Granted
Published in Swissreg on 06.04.2022
Parties
Inventor
Minneapolis, MN 55405, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.